Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral acetaminophen versus oral ibuprofen for closure of neonatal patent ductus arteriosus
IRCT20170801035441N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of acetaminophen and ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Patent ductus arteriosus closure, Duration of hospitalization and 1 more. Started Jun 2018; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20170801035441N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170801035441N1.